NCT06953934View on ClinicalTrials.gov

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 14, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

ABBV-932

Oral Capsule

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT06953934 - A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter